Phase I clinical trial evaluating the safety and anti-tumor activity of ADP-A2M10 SPEAR T-cells in patients with MAGE-A10+ head and neck, melanoma, or urothelial tumors

ABSTRACT: Expression of several gene groups was compared between pre-treatment tumour samples from patients with either head&neck, melanoma or urothelial cancers

ORGANISM(S): Homo sapiens

PROVIDER: GSE195530 | GEO | 2022/01/28

REPOSITORIES: GEO